利用含有AC基序的C-to-G报告系统测试这些蛋白的活性，发现来源于Acinetobacter junii的TadA在报告系统上有高达4%的编辑活性。随后，研究团队对TadA家族的同源性进行了分析，鉴定了20个高度保守的位点，对高度保守氨基酸附近的非保守氨基酸进行了精氨酸突变。

By 2050, around 2 million people — the majority aged over 70 — could die from drug-resistant infections each year.

Researchers say "now is the time to act" to protect people across the world from the threat posed by resistance to drugs that ...

University of Liverpool researchers have engineered a library of strains that can be used to develop new antibacterial ...

MEMANT-3310 is under clinical development by Antabio and currently in Phase I for Acinetobacter Infections. According to GlobalData, Phase ...

In promising experiments, phage therapy forces bacteria into a no-win dilemma that lowers their defenses against drugs they’d ...

High-profile medicolegal cases in Mumbai and Bangalore shed light on healthcare challenges, emphasising the need for ...

University of Liverpool researchers have engineered a library of strains that can be used to develop new antibacterial ...

Monoclonal antibodies—treatments developed by cloning a cell that makes an antibody—could help provide an answer to the ...

A new global analysis warns that antibiotic resistance could lead to over 39 million deaths by 2050, highlighting an urgent ...

Scientists say potentially deadly bacteria - including E.coli and C.diff - travel at an altitude of up to 10,000 feet.